In our actual preclinical intervention study, we surveyed the potential cell-protective and immunomodulatory effects of exogenous PACAP during acute colitis of enteropathogenic origin, for the very first time, applying C. jejuni infected secondary abiotic IL-10−/− mice. Here, ADCYAP1 is linked to colitis.